Cercar
01/02/2022
Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834
Meek, CL, Oram, RA, McDonald, TJ, Feig, DS, Hattersley, AT, Murphy, HR, Corcoy R., CHICO BALLESTEROS, ANA ISABEL, CONCEPTT Collaborative Grp. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834. DIABETES CARE. 2022; 45(2)DOI:10.2337/dci21-0054. PMID:35050370. IF:16.200(Q1/1D).
01/01/2022
Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world
Franch-Nadal J., Granado-Casas M., Mata-Cases M., Ortega E., Vlacho B., Mauricio D.. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.005. PMID:36336605. IF:2.900(Q2/5D).
01/01/2022
Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia
Genua I., Franch-Nadal J., Navas E., Mata-Cases M., Giménez-Pérez G., Vlacho B., Mauricio D., Goday A.. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.1015614. PMID:36531459. IF:5.200(Q1/3D).
01/01/2022
Dysglycemia in young women attenuates the protective effect against fatty liver disease
Pérez-Montes de Oca A., Julián M.T., Pera G., Caballería L., Morillas R., Torán P., Expósito C., Franch-Nadal J., Mauricio D., Alonso N.. Dysglycemia in young women attenuates the protective effect against fatty liver disease. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.971864. PMID:36479218. IF:5.200(Q1/3D).